The attenuation of eosinophilia by the administration of monoclonal antibodies to CCR3 consistently correlates with impairment in worm elimination following primary intraperitoneal Brugia pahangi infections in mice. Host protection was unimpaired in mice deficient in eosinophil peroxidase (EPO) or major basic protein 1 (MBP-1), suggesting that eosinophils are essential in host protection but that neither EPO nor MBP-1 alone is.Despite the consistent association of eosinophilia with parasitic infections, evidence supporting a host-protective role in vivo remains elusive (1-4, 16, 22). The function of eosinophils has been studied by modulating their numbers by manipulating interleukin-5 levels (5) (13) or depleting them selectively with a monoclonal antibody against the eotaxin receptor CCR3 (8). Eosinophilia correlates with improved host protection in Angiostrongylus cantonensis (19), Strongyloides ratti (17), Strongyloides stercoralis (12), Onchocerca volvulus (14), and Litomosoides sigmodontis (15) infections. In contrast, the depletion of eosinophils did not alter the course of Schistosoma mansoni (20), Mesocestoides corti (13), and Trichuris muris (3) infections. In the case of filarial parasites, eotaxin and eosinophils have been shown to play a role in host protection (21).The role of eosinophil granule constituents in host protection is also unclear. Purified eosinophil granule proteins have been shown to effectively kill Brugia microfilariae (11), schistosomulae (2), and Trichinella spiralis newborn larvae (10) in vitro. have shown that the death of onchocercal microfilariae following amocarzine treatment was associated with eosinophil degranulation. Electron microscopy analyses showed apposition of eosinophil granule material on the microfilarial surface. However, the requirement of eosinophil granule protein for in vivo host protection has not been studied extensively. In a recent study, EPO Ϫ/Ϫ and wild-type (WT) mice challenged with O. volvulus manifested similar parasite recoveries, suggesting that eosinophil peroxidase (EPO) is not required for host protection in this model (1). In order to investigate the role of the eosinophil granule proteins in host protection, we have now examined the course of Brugia pahangi infection in mice that have undergone targeted mutations in the genes encoding two of the major proteins in the eosinophil granules.C57BL/6 (hereafter WT) mice were obtained from the Jackson Laboratory (Bar Harbor, Maine). EPO Ϫ/Ϫ and MBP-1 Ϫ/Ϫ mice (6, 7) were transferred from the Mayo Clinic, Scottsdale, Arizona, where they were generated and backcrossed with C57BL/6 mice for six generations at the UCHC AAALACaccredited facility. Brugia pahangi third-stage larvae (L3) were provided by one of the following sources: TRS Inc. Monoclonal antibodies against rat RT 6.1 (DS4.23) and 6.2 (6A5) were obtained from Dale Greiner, UMass Medical Center, Worcester, MA. Antibodies were enriched from hybridoma ascites fluid by 50% ammonium sulfate precipitation. The precipitate was dialyzed against phos...